Israeli Cannabinoid Biotech Therapix IPOs on NASDAQ

therapix bio
Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

TEL AVIV, Israel, March 22, 2017 /PRNewswire/ —

Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based drugs, today announced the pricing of its

... read more at: